Status:
RECRUITING
Identification of New Prognostic Markers for Breast Cancer.
Lead Sponsor:
University Hospital, Grenoble
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Candidate markers have been identified thanks to an original approach developed by our research team aiming at detecting ectopic gene expression using public pan-genomic breast cancer data. The same a...
Detailed Description
Following a diagnosis of breast cancer, the most immediate challenges in patient management are the determination of prognosis and the identification of the most appropriate neoadjuvant and adjuvant s...
Eligibility Criteria
Inclusion
- Adult female patients with breast cancer
Exclusion
- Presence of another cancer, excluding basal cell cancers or pre-neoplastic lesions of the cervix.
- Subject under guardianship or subject deprived of liberty
- Impossibility of collecting information on exposure (subjects recently arrived in France, foreign language, etc.)
- Male patients
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2033
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT03436069
Start Date
January 1 2011
End Date
December 31 2033
Last Update
February 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Anne-Cécile PHILIPPE
Grenoble, France, 38043